These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 26369723)
1. A knot polymer mediated non-viral gene transfection for skin cells. Cutlar L; Gao Y; Aied A; Greiser U; Murauer EM; Zhou D; Wang W Biomater Sci; 2016 Jan; 4(1):92-5. PubMed ID: 26369723 [TBL] [Abstract][Full Text] [Related]
2. Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa. Chen M; Kasahara N; Keene DR; Chan L; Hoeffler WK; Finlay D; Barcova M; Cannon PM; Mazurek C; Woodley DT Nat Genet; 2002 Dec; 32(4):670-5. PubMed ID: 12426566 [TBL] [Abstract][Full Text] [Related]
3. Development of Minicircle Vectors Encoding COL7A1 Gene with Human Promoters for Non-Viral Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa. Wang X; Alshehri F; Manzanares D; Li Y; He Z; Qiu B; Zeng M; A S; Lara-Sáez I; Wang W Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884578 [TBL] [Abstract][Full Text] [Related]
4. Construction of skin equivalents for gene therapy of recessive dystrophic epidermolysis bullosa. Gache Y; Baldeschi C; Del Rio M; Gagnoux-Palacios L; Larcher F; Lacour JP; Meneguzzi G Hum Gene Ther; 2004 Oct; 15(10):921-33. PubMed ID: 15585108 [TBL] [Abstract][Full Text] [Related]
5. Correction of Recessive Dystrophic Epidermolysis Bullosa by Transposon-Mediated Integration of COL7A1 in Transplantable Patient-Derived Primary Keratinocytes. Latella MC; Cocchiarella F; De Rosa L; Turchiano G; Gonçalves MAFV; Larcher F; De Luca M; Recchia A J Invest Dermatol; 2017 Apr; 137(4):836-844. PubMed ID: 28027893 [TBL] [Abstract][Full Text] [Related]
6. Fibroblasts show more potential as target cells than keratinocytes in COL7A1 gene therapy of dystrophic epidermolysis bullosa. Goto M; Sawamura D; Ito K; Abe M; Nishie W; Sakai K; Shibaki A; Akiyama M; Shimizu H J Invest Dermatol; 2006 Apr; 126(4):766-72. PubMed ID: 16439972 [TBL] [Abstract][Full Text] [Related]
7. Functional correction of type VII collagen expression in dystrophic epidermolysis bullosa. Murauer EM; Gache Y; Gratz IK; Klausegger A; Muss W; Gruber C; Meneguzzi G; Hintner H; Bauer JW J Invest Dermatol; 2011 Jan; 131(1):74-83. PubMed ID: 20720561 [TBL] [Abstract][Full Text] [Related]
8. Efficient and Robust Highly Branched Poly(β-amino ester)/Minicircle Zeng M; Alshehri F; Zhou D; Lara-Sáez I; Wang X; Li X; A S; Xu Q; Zhang J; Wang W ACS Appl Mater Interfaces; 2019 Aug; 11(34):30661-30672. PubMed ID: 31390173 [TBL] [Abstract][Full Text] [Related]
9. Gene-Corrected Fibroblast Therapy for Recessive Dystrophic Epidermolysis Bullosa using a Self-Inactivating COL7A1 Retroviral Vector. Jacków J; Titeux M; Portier S; Charbonnier S; Ganier C; Gaucher S; Hovnanian A J Invest Dermatol; 2016 Jul; 136(7):1346-1354. PubMed ID: 26994967 [TBL] [Abstract][Full Text] [Related]
10. Mutation analysis and characterization of COL7A1 mutations in dystrophic epidermolysis bullosa. Dang N; Murrell DF Exp Dermatol; 2008 Jul; 17(7):553-68. PubMed ID: 18558993 [TBL] [Abstract][Full Text] [Related]
11. Characterization of mutant type VII collagens underlying the inversa subtype of recessive dystrophic epidermolysis bullosa. Woodley DT; Cogan J; Mosallaei D; Yim K; Chen M J Dermatol Sci; 2021 Nov; 104(2):104-111. PubMed ID: 34674926 [TBL] [Abstract][Full Text] [Related]
12. Normal and gene-corrected dystrophic epidermolysis bullosa fibroblasts alone can produce type VII collagen at the basement membrane zone. Woodley DT; Krueger GG; Jorgensen CM; Fairley JA; Atha T; Huang Y; Chan L; Keene DR; Chen M J Invest Dermatol; 2003 Nov; 121(5):1021-8. PubMed ID: 14708601 [TBL] [Abstract][Full Text] [Related]
14. Phase I/II ex vivo gene therapy clinical trial for recessive dystrophic epidermolysis bullosa using skin equivalent grafts genetically corrected with a COL7A1-encoding SIN retroviral vector (GENEGRAFT). Hum Gene Ther Clin Dev; 2014 Jun; 25(2):65-6. PubMed ID: 24933565 [No Abstract] [Full Text] [Related]
15. A non-viral gene therapy for treatment of recessive dystrophic epidermolysis bullosa. Cutlar L; Zhou D; Hu X; Duarte B; Greiser U; Larcher F; Wang W Exp Dermatol; 2016 Oct; 25(10):818-20. PubMed ID: 27117059 [No Abstract] [Full Text] [Related]
16. Long-term follow-up of patients with recessive dystrophic epidermolysis bullosa in the Netherlands: expansion of the mutation database and unusual phenotype-genotype correlations. van den Akker PC; van Essen AJ; Kraak MM; Meijer R; Nijenhuis M; Meijer G; Hofstra RM; Pas HH; Scheffer H; Jonkman MF J Dermatol Sci; 2009 Oct; 56(1):9-18. PubMed ID: 19665875 [TBL] [Abstract][Full Text] [Related]
17. Gene therapy: pursuing restoration of dermal adhesion in recessive dystrophic epidermolysis bullosa. Cutlar L; Greiser U; Wang W Exp Dermatol; 2014 Jan; 23(1):1-6. PubMed ID: 24107073 [TBL] [Abstract][Full Text] [Related]